[Paraneoplastic syndromes (1)].
Although not rare, paraneoplastic syndromes develop in a minority of cancer patients. Their exact frequency seems to be underestimated. These syndromes are hereby described. Their clinical usefulness is of great importance: they can be the first sign of a malignancy and can be used as tumor markers. The diagnosis of paraneoplastic syndromes is often difficult. A "diagnosis score" is proposed in order to make the diagnosis easier.
Lortholary
A
A
Centre Paul-Papin, Angers, France.
Cossee
M
M
Gamelin
E
E
Larra
F
F
D002275:Carcinoid Heart Disease / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology*; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000209:etiology; D009369:Neoplasms / Q000150:complications*; D009422:Nervous System Diseases / Q000209:etiology*; D009384:Paraneoplastic Endocrine Syndromes; D010257:Paraneoplastic Syndromes; D012216:Rheumatic Diseases / Q000209:etiology*; D012871:Skin Diseases / Q000209:etiology*
Les syndromes paranéoplasiques (1re partie).